Ferrlecit (Sodium Ferric Gluconate Complex)
Brand Names: Ferrlecit
Methodology & AI Transparency ⓘ
Ferrlecit (Sodium Ferric Gluconate Complex) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: As a proprietary parenteral iron replacement presentation registered by sanofi-aventis U.S.
- 2 Real-world patient consensus: Registered under RxNorm 261123 and SPL 2025-10-07, pairing Ferrlecit packaging with active ingredient Sodium Ferric Gluconate Complex.
- 3 Typical cash cost range: Public pharmacy ledger: $447.48 low cash benchmark vs. $1185.82 chain retail average ($6.0970/unit CMS NADAC).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Ferrlecit (Sodium Ferric Gluconate Complex) include nausea (11.6%), headache (10.2%), dizziness (9.5%).
Ask our AI Specialists anything about Ferrlecit (Sodium Ferric Gluconate Complex)
Ferrlecit (Sodium Ferric Gluconate Complex) Mechanism, CYP450 Pathways & DailyMed Monograph
As a proprietary parenteral iron replacement presentation registered by sanofi-aventis U.S. LLC, Ferrlecit supplies active moiety Sodium Ferric Gluconate Complex (cross-referenced at /meds/sodium-ferric-gluconate-complex) in 12.5 mg/mL Injection; 10 mL (NDC 0024-2794, 0024-2792; SPL 2025-10-07). Clinical prescribing and dispensing guidelines focus on Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6.
The active constituent inside Ferrlecit—Sodium Ferric Gluconate Complex—functions as a targeted parenteral iron replacement agent with class-characteristic hepatorenal disposition. While therapeutic target engagement mirrors generic Sodium Ferric Gluconate Complex, Ferrlecit (registered by sanofi-aventis U.S. LLC, SPL 2025-10-07) specifies proprietary packaging (0024-2794, 0024-2792) and 12.5 mg/mL Injection; 10 mL quality controls alongside a $6.0970/unit NADAC acquisition baseline.
Following administration (12.5 mg/mL Injection), Ferrlecit (Sodium Ferric Gluconate Complex) achieves Complete (~100%) parenteral systemic delivery for Ferrlecit (Sodium Ferric Gluconate Complex) (12.5 mg/mL Injection) bioavailability and rapid intravascular/parenteral onset within 15–45 minutes after ferrlecit (sodium ferric gluconate complex) administration onset, governed by a Biphasic clearance with 11–17 hr terminal t½ under Ferrlecit (Sodium Ferric Gluconate Complex) maintenance terminal half-life through hepatic enzymatic processing and renal clearance proportional to creatinine clearance (ferrlecit (sodium ferric gluconate complex)).
Before initiating Ferrlecit (Sodium Ferric Gluconate Complex) at 12.5 mg/mL Injection, clinical safety checklists rule out documented intolerance or hypersensitivity reaction involving sodium ferric gluconate complex (parenteral iron replacement); concurrent restricted medications flagged in section 4/7 of the ferrlecit (sodium ferric gluconate complex) dailymed monograph (261123). Logged tolerability patterns center on nausea (11.6% of reports), headache (10.2% of reports), dizziness (9.5% of reports).
Divalent and trivalent cations bind Ferrlecit (Sodium Ferric Gluconate Complex) intraluminally and blunt peak oral plasma concentrations.
Assess baseline hepatic panels and interacting prescriptions when starting Ferrlecit (Sodium Ferric Gluconate Complex) (parenteral iron replacement).
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Documented intolerance or hypersensitivity reaction involving Sodium Ferric Gluconate Complex (parenteral iron replacement)
- Concurrent restricted medications flagged in Section 4/7 of the Ferrlecit (Sodium Ferric Gluconate Complex) DailyMed monograph (261123)
Logged Side-Effect Incidence (9 Reports)
Ferrlecit (Sodium Ferric Gluconate Complex) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Ferrlecit (Sodium Ferric Gluconate Complex))
Human clinical trial evidence for Ferrlecit (Sodium Ferric Gluconate Complex) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Ferrlecit (Sodium Ferric Gluconate Complex) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $6.0970/unit (~$182.91/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $1185.82 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 9 Anonymous DotMD Community Micro-Logs | $447.48 / mo | View logs ↓ |
Ferrlecit (Sodium Ferric Gluconate Complex) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Ferrlecit (Sodium Ferric Gluconate Complex) RxNorm Concept ID | 261123 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $6.0970 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $1185.82 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $447.48 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 82.00% Worth It (9 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Ferrlecit (Sodium Ferric Gluconate Complex) Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Ferrlecit (Sodium Ferric Gluconate Complex): FDA labeling (2025-10-07, NDC 0024-2794), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Ferrlecit (Sodium Ferric Gluconate Complex) community threads and patient logs by age, biological sex, dosage, and treatment duration.